Presenilin Complex Assembly and Intracellular Traffic
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
A2005251
Summary
Alzheimer’s disease is a prevalent, adult-onset neurodegenerative disease that is characterized by progressive impairments in cognition and memory. Protein aggregates termed amyloids lead to the destruction of neurons, the formation of harmful brain lesions, and eventually culminate in the development of Alzheimer’s disease. Intensive research has identified the source of these harmful protein fragments as the amyloid precursor protein (APP). Studies have also identified proteins termed presenilins, as well as 3 additional accessory proteins, which function together as a unit to divide the APP. While each of these proteins has normal and essential biological functions, in the disease state they seem to function in a somewhat deregulated manner. Dr. Aridor believes greater understanding of the mechanisms that regulate the presenilin complex activity will in the future enable us to preserve its essential functions while eliminating harmful activity.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Regulatory mechanisms underlying endosomal targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory mechanisms underlying endosomal targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD